Madelaine B. Rañola

发表

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits

J. Jankovic, N. Schuff, Z. Mari, 2015, Movement disorders : official journal of the Movement Disorder Society.

Reduced T helper and B lymphocytes in Parkinson's disease

G. Halliday, C. Stevens, M. Morel-Kopp, 2012, Journal of Neuroimmunology.

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Norbert Schuff, Arthur W. Toga, John Seibyl, 2018, Annals of clinical and translational neurology.

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

Yen F. Tai, A. Singleton, P. Muglia, 2020, The Lancet Neurology.

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

Yen F. Tai, P. Muglia, J. Jankovic, 2022, npj Parkinson's Disease.

Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.

G. Halliday, D. Rowe, N. Dzamko, 2013, Journal of Parkinson's disease.

Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker

G. Halliday, D. Rowe, N. Dzamko, 2016, Scientific Reports.

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).

Yen F. Tai, P. Muglia, J. Jankovic, 2019, Parkinsonism & related disorders.

Reduced T helper and B lymphocytes in Parkinson's disease

G. Halliday, C. Stevens, M. Morel-Kopp, 2012, Journal of Neuroimmunology.

The Road Less Travelled: Identifying Support Needs in Lewy Body Dementia

Madelaine B. Rañola, 2021, Australasian Journal of Neuroscience.